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OBJECTIVES We measured end-tidal CO2 pressure (PETCO2) during exercise and investigated the
relationship between PETCO2 and exercise capacity, ventilatory parameters and cardiac
output to determine the mechanism(s) of changes in this parameter.
BACKGROUND It is unclear whether PETCO2 is abnormal at rest and during exercise in cardiac patients.
METHODS Cardiac patients (n 5 112) and normal individuals (n 5 29) performed exercise tests with
breath-by-breath gas analysis, and measurement of cardiac output and arterial blood gases.
RESULTS PETCO2 was lower in patients than in normal subjects at rest and decreased as the New York
Heart Association class increased, whereas the partial pressure of arterial CO2 did not differ
among groups. Although PETCO2 increased during exercise in patients, it remained lower
than in normal subjects. PETCO2 in relation to cardiac output was similar in patients and
normal subjects. PETCO2 at the respiratory compensation point was positively correlated
with the O2 uptake (r 5 0.583, p , 0.0001) and the cardiac index at peak exercise (r 5 0.582,
p , 0.0001), and was negatively correlated with the ratio of physiological dead space to the
tidal volume. The sensitivity and specificity of PETCO2 to predict an inadequate cardiac
output were 76.6% and 75%, respectively, when PETCO2 at respiratory compensation point
and a cardiac index at peak exercise that were less than the respective control mean–2 SD
values were considered to be abnormal.
CONCLUSIONS PETCO2 was below normal in cardiac patients at rest and during exercise. PETCO2 was
correlated with exercise capacity and cardiac output during exercise, and the sensitivity and
specificity of PETCO2 regarding decreased cardiac output were good. PETCO2 may be a
new ventilatory abnormality marker that reflects impaired cardiac output response to exercise
in cardiac patients diagnosed with heart failure. (J Am Coll Cardiol 2000;36:242–9) © 2000
by the American College of Cardiology
Patients with cardiac diseases, especially those with conges-
tive heart failure, frequently experience exertional dyspnea
(1–5). They show a heightened ventilatory response to
exercise, with the magnitude of the increase in ventilation
related to the severity of heart failure (6,7). An inadequate
cardiac output in cardiac patients during exercise causes
hypoperfusion of working muscles, leading to anaerobic
metabolism even at a low exercise intensity, and subse-
quently to lactate accumulation, acidosis and tissue hypoxia
(3,8–11). These factors may contribute to muscle fatigue
and shortness of breath in cardiac patients (3,10–13). On
the other hand, cardiac patients often develop pulmonary
congestion, which may reduce lung compliance, stimulate J
receptors and induce rapid and shallow ventilation (14–16).
Decreased cardiac output and pulmonary congestion in
cardiac patients may cause changes in the distribution of
ventilation and perfusion in the lungs (ventilation-perfusion
mismatch), leading to an increased ratio of physiologic dead
space to tidal volume (7,17,18). Thus, the ventilatory
equivalent for carbon dioxide (CO2) output and the slope of
minute ventilation plotted as a function of CO2 output are
abnormally high in these patients (4,5,19).
In normal subjects, end-tidal CO2 pressure (PETCO2) is
slightly lower than the partial pressure of arterial CO2
(PaCO2) at rest, but becomes higher than PaCO2 during
exercise as the work load increases (20–22). In patients with
obstructive or restrictive lung diseases and with silent
pulmonary embolism, PETCO2 is below normal at rest and
during exercise (23–25). PETCO2 is also decreased in
animals and patients with a decreased cardiac output who
undergo cardiopulmonary resuscitation (26–29). These
findings suggest that PETCO2 is decreased in some patho-
physiologic conditions associated with a ventilation-
perfusion mismatch and a decreased cardiac output. Al-
though there have been many studies reporting
abnormalities in ventilatory parameters in cardiac patients,
(3,8,9) only one report has shown that PETCO2 at peak
exercise is positively correlated with peak O2 uptake in
patients with chronic heart failure (7). Therefore, it has not
been fully understood whether PETCO2 is abnormal at rest
and during exercise in cardiac patients. Moreover, if so, it is
also unknown what mechanism(s) might be responsible for
the decreased PETCO2 in cardiac patients.
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We measured PETCO2 in cardiac patients and normal
subjects to determine whether PETCO2 is abnormal in
these patients. PETCO2 is determined by the venous
PCO2, the degree of the ventilation-perfusion mismatch,
and pulmonary blood flow (cardiac output) (30). Therefore,
we also investigated the relationships of PETCO2 with
exercise capacity, cardiac output and ventilatory parameters,
including CO2 output, minute ventilation and the slope of
the minute ventilation-CO2 output relationships to clarify
the mechanism(s) of decreased PETCO2. We measured
ventilatory parameters by breath-by-breath gas analysis,
with simultaneous measurement of cardiac output by the
dye dilution method.
METHODS
Subjects
We investigated 112 patients with cardiac diseases and 29
age-matched normal control subjects. Patients consisted of
67 men and 45 women with an average age of 53 6 1 (SE)
years. The underlying heart diseases included valvular heart
diseases in 79 patients, old myocardial infarction in 24
patients, and idiopathic dilated cardiomyopathy in 9 pa-
tients. According to the New York Heart Association
(NYHA) functional classification, 31 patients were in class
I, 35 in class II, and 46 in class III. According to Weber and
Janicki’s functional classification (3), 20 patients were in
class A (peak O2 uptake [V˙O2] . 20 ml/min/kg), 36 in
class B (peak V˙O2 16–20 ml/min/kg), 52 in class C (peak
V˙O2 10–15 ml/min/kg), and 4 in class D (peak V˙O2 , 10
ml/min/kg). Normal control subjects consisted of 20 men
and 9 women, whose average age was 51 6 3 years. They
had no symptoms, and no evidence of significant disease was
detected by physical examination, chest radiography, resting
and exercise electrocardiograms (ECGs), or routine labora-
tory tests.
Excluded from the study were patients with aortic steno-
sis, unstable angina, congenital heart diseases with shunt,
heart failure in NYHA class IV, metabolic diseases or
primary lung diseases. No patient had a myocardial infarc-
tion within one month of study enrollment. All patients
were clinically stable at the time of the study. Medications
were discontinued as follows: beta-blockers were discontin-
ued for at least seven days before initiation of the study, and
other medications such as digitalis, diuretics and vasodila-
tors were discontinued 24 h before the study. The study was
approved by the hospital ethics committee and informed
consent was obtained from all subjects.
Exercise Protocol and Expired Gas Analysis
Before the study, patients were asked to perform a famil-
iarization exercise test with expired gas analysis, and then a
symptom-limited exercise test on an electromagnetically
braked upright cycle ergometer (Corival with ramp slope
controller, Lode, Groningen, Holland) at least 2 h after a
meal. The exercise protocol and gas exchange analysis have
been previously described (31,32). In brief, after a 4-min
rest on the cycle ergometer, exercise was started at 20 W for
a 4-min warmup and was then increased in 1-W increments
every 6 s. Patients were monitored by a 12-lead electrocar-
diogram using a stress system (ML-5000, Fukuda Denshi,
Tokyo, Japan). Blood pressure was measured by an auto-
matic indirect cuff manometer (STBP-780, Colin, Aichi,
Japan) every minute. Patients stopped exercising because of
leg fatigue or dyspnea. Expired gases were measured con-
tinuously in all patients on a breath-by-breath basis using an
expired gas analyzer (RM-300, Minato Ikagaku, Osaka,
Japan). Ventilatory parameters, including oxygen (O2) up-
take, CO2 output and minute ventilation, were calculated.
Patients sometimes hyperventilated in anticipation of the
tests and this tended to initially decrease PETCO2. When
the patients hyperventilated, resting time was extended
beyond 4 min until a stable PETCO2 was obtained.
Cardiac Output Measurement and Blood Gas Analysis
During cardiopulmonary exercise testing, cardiac output
was measured in all subjects by the dye dilution method
using an earpiece with a dye densitometer (MCL-4200,
Nihon Coden, Tokyo, Japan) (33). A small cannula was
placed in the antecubital vein, and 5 mg of indocyanine
green was injected through this cannula at rest, at peak
exercise, and every 2 min during exercise.
Arterial blood gases were measured in 53 cardiac patients
and 15 normal control subjects. The underlying heart
diseases included valvular heart diseases in 30 patients, old
myocardial infarction in 18 patients and idiopathic dilated
cardiomyopathy in 5 patients. Another small cannula was
inserted in the brachial artery, and blood samples were
obtained every minute throughout the test. The partial
pressure of arterial O2 (PaO2) and PaCO2 and the pH were
measured with a standard blood gas analyzer (288 Blood
Gas System, Chiba Corning Co., Medfield, Massachusetts).
Derived Parameters
The minute ventilation-CO2 output curve obtained during
exercise can be closely fitted as a linear line (6,19). The slope
of the minute ventilation-CO2 output relation from the
start of ramp exercise to the respiratory compensation point
Abbreviations and Acronyms
PETCO2 5 end-tidal CO2 pressure
PaCO2 5 partial pressure of arterial CO2
P[a-ET]CO2 5 arterial–end-tidal CO2 difference
NYHA 5 New York Heart Association
V˙O2 5 O2 uptake
VD/VT 5 the physiologic dead space to tidal
volume ratio
%FVC 5 forced vital capacity expressed as
percent of predicted
%FEV1 5 forced expiratory volume in 1 s
expressed as percent of predicted
VA/Q 5 ventilation/perfusion
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was calculated by linear regression analysis using the values
of minute ventilation and CO2 output.
The physiologic dead space to tidal volume ratio (VD/
VT) was calculated using the equation (34):
VD/VT 5 ~PaCO2 2 PeCO2!/PaCO2 2 VDM/VT,
where VT is tidal volume, PeCO2 is mixed expired PCO2
and VDM is breathing valve dead space.
Statistics
Comparisons of data among the four groups were per-
formed using one-way analysis of variance (ANOVA)
followed by Dunnett’s multiple comparison test. The effects
of exercise on PETCO2 and PaCO2 variables were com-
pared by two-way ANOVA with repeated measures. Dif-
ferences between the means at each time point within and
between groups were performed by one-way ANOVA
followed by Dunnett’s multiple comparison test. The cor-
relation coefficients were determined using the least-squares
method. A value of p , 0.05 was considered significant. All
data are shown as the mean 6 SE.
RESULTS
The anaerobic threshold, oxygen uptake and work rate at
peak exercise were lower in the patients than in the control
subjects (Table 1). These parameters decreased with in-
creases in the NYHA class. The slope of minute ventilation-
CO2 output relationship was higher in the patients than in
the control subjects, and became higher with increases in
the NYHA class.
PETCO2 was lower in cardiac patients at rest than in
normal subjects and decreased with increases in the NYHA
class (control, 35.5 6 0.4; NYHA I, 34.4 6 0.6; II, 32.7 6
0.7; III, 32.2 6 0.5 mm Hg; p 5 0.003, Fig. 1). PETCO2
increased during exercise in patients and control subjects.
There was a significant difference in the change of PETCO2
during exercise among the four groups at each time point
(one way-ANOVA at each time point: rest p 5 0.0016,
20W p 5 0.0001, 30W p 5 0.0001, AT p 5 0.0001, RC
p 5 0.0001, Peak p 5 0.0001). PETCO2 was significantly
lower in the cardiac patients than in the normal subjects,
and the difference became more marked as the exercise work
rate increased.
PETCO2 was lower in the cardiac patients than in the
normal subjects at the same CO2 output during exercise,
and decreased with increases in the NYHA class (Fig. 2).
PETCO2 was lower in cardiac patients than in normal
Figure 1. End-tidal CO2 pressure (PETCO2) at rest and during exercise according to the NYHA functional class. There was a significant difference in
the change of PETCO2 during exercise among the four groups at each time point (one way-ANOVA at each time point: rest p 5 0.0016, 20 W p 5 0.0001,
30 W p 5 0.0001, AT p 5 0.0001, RC p 5 0.0001, Peak p 5 0.0001). AT indicates anaerobic threshold; RC 5 respiratory compensation point; P 5
peak exercise. Values are mean 6 SE. *p , 0.05 versus controls.
Table 1. Results of Exercise Testing
Controls
NYHA
I II III
V˙E-V˙CO2
slope
26.0 6 1.3 26.5 6 1.1 33.8 6 1.6*† 38.5 6 1.6*†‡
AT
(ml/min/kg)
13.3 6 0.6 13.5 6 0.5 11.7 6 0.3*† 9.7 6 0.4*†‡
Peak V˙O2
(ml/min/kg)
24.7 6 0.9 21.1 6 0.7* 15.7 6 0.4*† 12.4 6 0.3*†‡
Peak CI
(l/min/m2)
9.41 6 0.40 7.02 6 0.32* 4.77 6 0.21*† 3.83 6 0.15*†‡
Peak work
rate (W)
113 6 7 97 6 4* 79 6 3*† 54 6 4*†‡
NYHA indicates New York Heart Association functional classification; V˙E-V˙CO2
slope, the slope of minute ventilation (V˙E)-CO2 output (V˙CO2) relationship; AT,
anaerobic threshold; V˙O2, oxygen uptake; CI, cardiac index.
Values are the mean 6 SE, *p , 0.05 vs. controls, †p , 0.05 vs. NYHA I, ‡p ,
0.05 vs. NYHA II.
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subjects during exercise when compared at the same values
of minute ventilation, tidal volume and respiratory rate, and
also became lower as the functional class worsened.
The relationship between PETCO2 and cardiac index at
rest and during exercise is also demonstrated in Figure 3.
The relationship between PETCO2 and cardiac index was
linear. In cardiac patients, the cardiac index was smaller
than in normal subjects at rest and during exercise, and as
the cardiac index decreased the PETCO2 also decreased.
The decrease of PETCO2 was more marked in patients
with severe heart failure, as indicated by their NYHA
functional class.
PETCO2 at the respiratory compensation point corre-
lated positively with the cardiac index at peak exercise (r 5
0.582, p , 0.0001, Fig. 4). If less than 38.5 mm Hg (that
is, mean–2 SD) of PETCO2 at respiratory compensation
point and a cardiac index of 5.11 l/min/m2 at peak exercise
were considered to be abnormal in the control subjects,
abnormally low values of PETCO2 were observed in 49 of
the 64 patients who had decreased cardiac output. Thirty-
six of the 48 patients who had normal cardiac output had a
Figure 2. End-tidal CO2 pressure (PETCO2) at rest and during exercise in relation to CO2 output (V˙CO2), minute ventilation (V˙E), tidal volume (VT),
and respiratory rate (RR) at rest (R), during 20 W warming-up (WU), at anaerobic threshold (AT), at respiratory compensation point (RC), and at peak
exercise (P) according to the NYHA functional class. Values are mean 6 SE.
Figure 3. End-tidal CO2 pressure (PETCO2) in relation to the cardiac
index (CI) at rest, at 20 W, 40 W, and 60 W during exercise according to
the NYHA functional class. Values are mean 6 SE.
Figure 4. Relationships of end-tidal CO2 pressure (PETCO2) at the
respiratory compensation (RC) point with the cardiac index at peak
exercise in 112 cardiac patients and 29 normal subjects. Dotted lines
indicate mean–2SD values of PETCO2 at the respiratory compensation
point and the cardiac index at peak exercise in the normal control subjects.
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normal level of PETCO2. Thus, the sensitivity and speci-
ficity of PETCO2 for decreased cardiac output were 76.6%
and 75.0%, respectively.
PETCO2 at the respiratory compensation point corre-
lated positively with O2 uptake at peak exercise (r 5 0.583,
p , 0.0001, Fig. 5). Moreover, PETCO2 at the respiratory
compensation point was correlated with the slope of minute
ventilation-CO2 output relationship (r 5 20.784, p ,
0.0001).
In the subgroup of 53 patients and 15 normal subjects in
whom arterial blood gases were measured, PaCO2 was
similar in both groups at rest and during exercise (Fig. 6).
PETCO2 was lower than PaCO2 at rest in both patients
and control subjects, but P(a-ET)CO2 was greater in the
patients than in the control subjects (9.54 6 0.33 vs. 6.59 6
0.55 mm Hg, p 5 0.0001). There was a significant
difference in the change between PaCO2 and PETCO2
variables and interaction with time both in the patients
(variables p 5 0.0001, interaction p 5 0.0001, by ANOVA)
and in the control subjects (variables p 5 0.0001, interaction
p 5 0.0001, by ANOVA). At peak exercise, PETCO2
increased above PaCO2 in control subjects, but remained
below PaCO2 in patients. PETCO2 at the respiratory
compensation point was negatively correlated with the ratio
of physiologic dead space to the tidal volume (r 5 20.494,
p , 0.0001, Fig. 7).
PaO2 was similar in both the patient group and the
normal control group, at rest and during exercise (at peak
exercise; 93.0 6 2.5 vs. 95.9 6 1.9 mm Hg, p 5 0.56).
There were no intergroup differences in PAO2 at rest or
during exercise. P(A-a)O2 was similar in both groups at rest
and during exercise (at peak exercise; 18.9 6 2.8 vs. 19.3 6
1.7 mm Hg, p 5 0.92).
Cardiac patients had lower values of forced vital capacity
expressed as percent of predicted (%FVC) than did control
subjects (control, 103 6 3%; NYHA I, 94 6 4%; II, 85 6
3%; III, 79 6 3%; p 5 0.0001). Similarly, patients had
lower values of forced expiratory volume in 1 s expressed as
percent of predicted (%FEV1) than did control subjects
(control, 99 6 3%; NYHA I, 88 6 5%; II, 73 6 3%; III,
72 6 3%, p 5 0.0001). However, patients had a similar
FEV1/FVC ratio to that in normal control subjects (control,
Figure 5. Relationships of end-tidal CO2 pressure (PETCO2) at the respiratory compensation (RC) point with O2 uptake (V˙O2) at peak exercise, or with
the slope of minute ventilation-CO2 output (V˙E-V˙CO2 slope) in 112 cardiac patients and 29 normal subjects.
Figure 6. End-tidal CO2 pressure (PETCO2) and arterial PCO2 (PaCO2) at rest and during exercise in 53 cardiac patients and 15 normal control subjects.
There was a significant difference in the change between PaCO2 and PETCO2 variables and interaction with time in both the patients (variables p 5
0.0001, interaction p 5 0.0001, by ANOVA) and control subjects (variables p 5 0.0001, interaction p 5 0.0001, by ANOVA). Peak indicates peak exercise.
Values are mean 6 SE. *; p , 0.05 versus normal controls. †; p , 0.05 versus PaCO2.
246 Matsumoto et al. JACC Vol. 36, No. 1, 2000
End-tidal CO2 in Cardiac Patients July 2000:242–9
86 6 3%; NYHA I, 77 6 3%; II, 71 6 4%; III, 74 6 3%;
p 5 0.17). PETCO2 correlated weakly with %FEV1 (r 5
0.236, p 5 0.038), but not with %FVC (r 5 0.195, p 5
0.087) or the FEV1/FVC ratio (r 5 0.105, p 5 0.42).
To investigate whether duration of exercise influences
PETCO2 during exercise, 7 normal control subjects (4 men
and 3 women) were asked to perform two ramp exercise
tests according to a rapidly and a slowly increasing ramp
protocol. The rapidly increasing protocol consisted of 1-W
increments every 3 s after 4 min warmup at 20 W, and the
slowly increasing protocol consisted of 1-W increments
every 6 s after the same warm-up. The duration of the ramp
exercise was shorter in the rapidly increasing protocol than
in the slowly increasing protocol (5.87 6 0.43 vs. 10.70 6
0.67 min, p 5 0.0002). The duration of ramp exercise did
not significantly alter the values of PETCO2 during exercise
(at the respiratory compensation point, rapidly increasing
protocol 46.2 6 1.3 vs. slowly increasing protocol 47.3 6
1.6 mm Hg, p 5 0.61).
DISCUSSION
Summary of the Findings
PETCO2 was lower at rest and during exercise in cardiac
patients compared with normal subjects, and decreased in
association with increases in the NYHA class. PETCO2
was correlated with cardiac output during exercise, and the
sensitivity and specificity of PETCO2 regarding decreased
cardiac output were good. PETCO2 was also positively
correlated with O2 uptake and was negatively correlated
with the slope of minute ventilation-CO2 output relation-
ship and the ratio of physiologic dead space to tidal volume.
On the other hand, P(A-a)O2 was similar in cardiac patients
and in the normal control subjects at rest and during
exercise. The present study demonstrates that PETCO2 is
abnormally regulated during exercise in patients with car-
diac disease, and that the decrease in PETCO2 is due to
changes in the pulmonary circulation (pulmonary blood
flow) and not in the airways.
Potential mechanisms
There was no intergroup difference in PaCO2 between
cardiac patients and normal subjects at rest and during
exercise in the present study, which is consistent with
previous findings (4). Although PaCO2 was greater than
PETCO2 at rest in both the patients and the normal
subjects, P(a-ET)CO2 was greater in cardiac patients than
in normal subjects at rest. During exercise, PETCO2
increased in both patients and normal subjects in this study.
In normal individuals, PETCO2 increases because of the
increased rate of CO2 delivery to the lungs associated with
the high rate of CO2 production during exercise (30).
During exhalation, the alveolar CO2 pressure (PaCO2)
approaches the venous PaCO2 because fresh air does not
dilute the alveolar gas. Because PETCO2 is the highest
PaCO2 in the alveolus during the respiratory cycle and the
arterial PaCO2 represents the average alveolar PaCO2,
PETCO2 is higher than PaCO2 during exercise in normal
individuals. However, in the present study, decreased
PETCO2 with positive P(a-ET)CO2 was observed in car-
diac patients during exercise. Although PETCO2 is almost
similar to PaCO2 in perfused alveoli, it is lower than PaCO2
in poorly perfused or high-ventilation/perfusion (VA/Q)
alveoli (22,23,30). Therefore, the greater P(a-ET)CO2 in
cardiac patients suggests decreased perfusion to more ven-
tilated alveoli (uneven alveolar VA/Q with high VA/Q units
or increased alveolar dead space) in these patients.
The increase in cardiac output during exercise was inap-
propriately small relative to the work load in cardiac patients
in the present study, which is consistent with previous
reports (3,8–11). PETCO2 is decreased in patients with a
decreased cardiac output who undergo cardiopulmonary
resuscitation (26,27,29), and changes in cardiac output in
patients with pacemakers influence PETCO2 at rest (35).
Therefore, the inappropriate increase in cardiac output
during exercise may have caused PETCO2 to decrease in
cardiac patients. Although Wasserman et al. (7), showed
that PETCO2 at peak exercise is positively correlated with
peak O2 uptake in patients with chronic heart failure, it has
been unknown what mechanism(s), especially cardiac out-
put, might be responsible for the decreased PETCO2 in
cardiac patients. On the other hand, this study clearly
demonstrated that PETCO2 increased in proportion to the
cardiac index from rest to respiratory compensation point
during exercise, and there were no intergroup differences in
the slope of the PETCO2-cardiac index relationship be-
tween normal subjects and cardiac patients (Fig. 3).
PETCO2 was correlated with cardiac index at peak exercise.
These results suggest that the relatively low pulmonary
blood flow is primarily responsible for the abnormally low
levels in PETCO2 during exercise, and that decreased
perfusion of ventilated alveoli was a likely cause of the
decreased PETCO2.
Figure 7. Relationships of end-tidal CO2 pressure (PETCO2) at the
respiratory compensation point with the ratio of physiologic dead space to
tidal volume (VD/VT) in 53 cardiac patients and 15 normal control
subjects.
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Because PETCO2 is also determined by the rate of CO2
production during exercise (30,34), a decrease in PETCO2
may reflect decreased CO2 production during exercise in
cardiac patients. However, PETCO2 was lower in cardiac
patients than in normal subjects at the same CO2 output,
which was almost equal to CO2 production in the whole
body. Therefore, the decrease in PETCO2 in these patients
was not due to decreased CO2 production. PETCO2 was
also lower in cardiac patients than in normal subjects at the
same levels of minute ventilation, respiratory rate, and tidal
volume, suggesting that the decrease in PETCO2 was not
related to abnormal ventilation patterns (rapid and shallow
breathing) or compensatory hyperventilation.
Minute ventilation is mainly determined by the rate of
CO2 production, the physiologic dead space, and the level at
which PaCO2 is regulated (20,22,36). Minute ventilation
increases linearly with CO2 output to maintain a relatively
stable arterial PCO2 during exercise (20,22). In the present
study, the slope of minute ventilation and CO2 output
relationship was steeper in cardiac patients than in normal
subjects and became more steep as the NYHA class became
more severe. This is consistent with the findings of previous
reports (6,19). This heightened ventilation was due to the
ventilation-perfusion mismatch and the increase in dead
space ventilation (7). Previous studies showed that height-
ened ventilation is due to failure of cardiac output to
increase appropriately, but not to pulmonary congestion
(4,19). In the present study, PETCO2 was negatively
correlated with the slope of the minute ventilation-CO2
output relationship and with the ratio of physiologic dead
space to the tidal volume. This study also showed that
P(A-a)O2 was normal at rest and during exercise in cardiac
patients, which was in agreement with the findings previ-
ously reported by Wasserman et al. (7). Taken together,
these findings suggested that the high ventilation-perfusion
mismatch occurs without a significant low ventilation-
perfusion mismatch (perfusion is reduced or absent in the
well-ventilated lung), and that the decrease in PETCO2 is
due to changes in the pulmonary circulation and not in the
airways. Therefore, the decreased PETCO2 in cardiac
patients is considered to be derived from the ventilation-
perfusion mismatch and the increased ratio of physiologic
dead space to tidal volume, which were due mainly to the
inappropriate increase in cardiac output during exercise.
Cardiac patients had lower values of %FVC and %FEV1
compared with normal control subjects, although their
FEV1/FVC ratio was similar to that of normal control
subjects. However, %FVC and %FEV1 were not markedly
reduced in the majority of cardiac patients, partly because
cardiac patients with underlying primary lung diseases were
excluded from this study. PETCO2 correlated weakly with
%FEV1, but not with %FVC or FEV1/FVC ratio. The
reason might be the relatively narrow spread of values of
%FEV1 in cardiac patients and normal control subjects
observed in this study. Furthermore, PETCO2 was more
influenced by the increase in cardiac output during exercise
than by pulmonary function.
Study Limitation
Patients entered in this study were cardiac patients with or
without chronic heart failure, but without lung diseases,
such as chronic obstructive lung diseases or restrictive
diseases. Therefore, the specificity as well as the sensitivity
of PETCO2 as a means to evaluate cardiac output reserve
are valid only for cardiac patients. Because PETCO2 may be
abnormally low in patients with lung diseases who have a
normal cardiac output (24), its sensitivity and specificity
might be less if those patients were included with cardiac
patients.
CONCLUSIONS
Patients with cardiac diseases had an abnormally low
PETCO2 at rest and during exercise compared with normal
subjects. PETCO2 was correlated with cardiac output dur-
ing exercise, and the sensitivity and specificity of PETCO2
regarding decreased cardiac output were good. PETCO2
was also correlated with the slope of the relationship
between minute ventilation and CO2 output, and the ratio
of physiologic dead space to the tidal volume. PETCO2
may be a new marker of ventilatory abnormalities that
reflects impaired cardiac output response to exercise in
cardiac patients.
Reprint requests and correspondence: Dr. Akihiro Matsumoto,
The Second Department of Internal Medicine, Faculty of Medi-
cine, University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo,
Japan, 113. E-mail: amatsu-tky@umin.u-tokyo.ac.jp.
REFERENCES
1. Harrison TR, Pilcher C. Studies in congestive heart failure. II. The
respiratory exchange during and after exercise. J Clin Invest 1930;8:
291–315.
2. Gazetopoulos N, Davis H, Oliver C, Deuchar D. Ventilation and
haemodynamic in heart disease. Br Heart J 1966;28:1–15.
3. Weber KT, Kinasewitz GT, Janicki JS, Fishman AP. Oxygen utiliza-
tion and ventilation during exercise in patients with chronic cardiac
failure. Circulation 1982;65:1213–23.
4. Sullivan MJ, Higginbotham MB, Cobb FR. Increased exercise venti-
lation in patients with chronic heart failure: intact ventilatory control
despite hemodynamic and pulmonary abnormalities. Circulation 1988;
77:552–9.
5. Koike A, Hiroe M, Taniguchi K, Marumo F. Respiratory control
during exercise in patients with cardiovascular disease. Am Rev Respir
Dis 1993;147:425–9.
6. Buller NP, Pool-Wilson PA. Mechanism of the increased ventilatory
response to exercise in patients with chronic heart failure. Br Heart J
1990;63:281–3.
7. Wasserman K, Zhang Y, Gitt A, Belardinelli R, Koike A, Lubarsky L,
Agostoni PG. Lung function and exercise gas exchange in chronic
heart failure. Circulation 1997;96:2221–7.
8. Franciosa JA, Ziesche S, Wilen M. Functional capacity of patients
with chronic left ventricular failure. Relationship of bicycle exercise
performance to clinical and hemodynamic characterization. Am J Med
1979;67:460–6.
9. Franciosa JA, Leddy CL, Wilen M, Schwartz DE. Relation between
248 Matsumoto et al. JACC Vol. 36, No. 1, 2000
End-tidal CO2 in Cardiac Patients July 2000:242–9
hemodynamic and ventilatory responses in determining exercise ca-
pacity in severe congestive heart failure. Am J Cardiol 1984;53:127–34.
10. Wilson JR, Martin JL, Schwartz D, Ferraro N. Exercise intolerance in
patients with chronic heart failure: role of impaired nutritive flow to
skeletal muscle. Circulation 1984;69:1079–87.
11. Sullivan MJ, Knight JD, Higginbotham MB, Cobb FR. Relation
between central and peripheral hemodynamics during exercise in
patients with chronic heart failure. Muscle blood flow is reduced with
maintenance of arterial perfusion pressure. Circulation 1989;80:769–
81.
12. Donald KW, Gloster J, Harris EA, Reeves J, Harris P. The production
of lactic acid during exercise in normal subjects and in patients with
rheumatic heart disease. Am Heart J 1961;62:494–510.
13. Fink LI, Wilson JR, Ferraro N. Exercise ventilation and pulmonary
artery wedge pressure in chronic stable congestive heart failure. Am J
Cardiol 1986;57:249–53.
14. Brown CCJ, Fry DL, Ebert RV. The mechanics of pulmonary
ventilation in patients with heart disease. Am J Med 1954;17:438–46.
15. Cook CD, Mead J, Schreiner GL, Frank NR, Craig JM. Pulmonary
mechanics during induced pulmonary edema in anesthetized dogs.
J Appl Physiol 1959;14:177–86.
16. Paintal AS. Mechanism of stimulation of type J pulmonary receptors.
J Physiol 1969;203:511–32.
17. Ingram R Jr, McFadden ER Jr. Respiratory changes during exercise in
patients with pulmonary venous hypertension. Prog Cardiovasc Dis
1976;19:109–15.
18. Reed JR, Ablett M, Cotes JE. Ventilatory responses to exercise and to
carbon dioxide in mitral stenosis before and after valvulotomy: causes
of tachypnoea. Clin Sci Mol Med 1978;54:9–16.
19. Metra M, Cas LD, Panina G, Visioli O. Exercise hyperventilation
chronic congestive heart failure, and its relation to functional capacity
and hemodynamics. Am J Cardiol 1992;70:622–8.
20. Wasserman K, Van Kessel AL, Burton GG. Interaction of physiolog-
ical mechanisms during exercise. J Appl Physiol 1967;22:71–85.
21. Whipp BJ, Wasseman K. Alveolar-arterial gas tension differences
during graded exercise. J Appl Physiol 1969;27:361–5.
22. Wasserman K, Whipp BJ. Exercise physiology in health and disease.
Am Rev Respir Dis 1975;112:219–49.
23. Sue DY, Oren A, Hansen JE, Wasserman K. Diffusing capacity for
carbon monoxide as a predictor of gas exchange during exercise.
N Engl J Med 1987;316:1301–6.
24. Liu Z, Vargas F, Stansbury D, Sasse SA, Light RW. Comparison of
the end-tidal arterial PCO2 gradient during exercise in normal subjects
and in patients with severe COPD. Chest 1995;107:1218–24.
25. Taniguchi S, Irita K, Sakaguchi Y, Takahashi S. Arterial to end-tidal
CO2 gradient as an indicator of silent pulmonary embolism (letter).
Lancet 1996;348:1451.
26. Garnett AR, Ornato JP, Gonzalez ER, Johnson EB. End-tidal carbon
dioxide monitoring during cardiopulmonary resuscitation. JAMA
1987;257:512–5.
27. Falk JL, Rackow EC, Weil MH. End-tidal carbon dioxide concen-
tration during cardiopulmonary resuscitation. N Engl J Med 1988;318:
607–11.
28. Gudipati CV, Weil MH, Bisera J, Deshmukh HG, Rackow EC.
Expired carbon dioxide: a noninvasive monitor of cardiopulmonary
resuscitation. Circulation 1988;77:234–9.
29. Gazmuri RJ, von Planta M, Weil MH, Rackow EC. Arterial PCO2 as
an indicator of systemic perfusion during cardiopulmonary resuscita-
tion. Crit Care Med 1989;17:237–40.
30. Wasserman K, Hansen JE, Sue DY, Whipp BJ, Casaburi R. Mea-
surements during integrative cardiopulmonary exercise testing. In:
Wasserman K, Hansen JE, Sue DY, Whipp BJ, Casaburi R, eds.
Principles of Exercise Testing and Interpretation. 2nd ed. Philadel-
phia: Lea & Febiger, 1994:52–79.
31. Itoh H, Taniguchi K, Koike A, Doi M. Evaluation of severity of heart
failure using ventilatory gas analysis. Circulation 1990;81 (suppl
II):II-31–II-37.
32. Matsumoto A, Hirata Y, Momomura S, et al. Effects of exercise on
plasma level of brain natriuretic peptide in congestive heart failure with
and without left ventricular dysfunction. Am Heart J 1995;129:139–
45.
33. Watanabe T, Kato K, Watanabe H, Koyama S. Determination of
cardiac output by earpiece dye dilution technique at rest and during
exercise. Jpn Heart J 1966;6:235–43.
34. Wasserman K, Hansen JE, Sue DY, Whipp BJ, Casaburi R. Calcu-
lations, formulae, and examples. In: Wasserman K, Hansen JE, Sue
DY, Whipp BJ, Casaburi R, eds. Principles of Exercise Testing and
Interpretation. 2nd ed. Philadelphia: Lea & Febiger, 1994:454–64.
35. Jones PW, French W, Weissman ML, Wasserman K. Ventilatory
responses to cardiac output changes in patients with pacemakers.
J Appl Physiol 1981;51:1103–7.
36. Wasserman K. Breathing during exercise. N Engl J Med 1978;298:
780–5.
249JACC Vol. 36, No. 1, 2000 Matsumoto et al.
July 2000:242–9 End-tidal CO2 in Cardiac Patients
